These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9177418)

  • 1. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism.
    Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada M; Luna JD; Olea N
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1989-94. PubMed ID: 9177418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.
    Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada-Charneco M; Lund del Castillo JD
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):279-85. PubMed ID: 9373448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ; Kinnunen K; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Nieminen M
    Osteoporos Int; 1999; 10(2):128-36. PubMed ID: 10501793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
    Kung AW; Yeung SS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1232-6. PubMed ID: 8772604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density trends in Indian patients with hyperthyroidism--effect of antithyroid therapy.
    Dhanwal DK; Gupta N
    J Assoc Physicians India; 2011 Sep; 59():561-2, 567. PubMed ID: 22334969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ; Kinnunen K; Volin L; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Ruutu T
    Bone Marrow Transplant; 1999 Feb; 23(4):355-61. PubMed ID: 10100579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist.
    Moghetti P; Castello R; Zamberlan N; Rossini M; Gatti D; Negri C; Tosi F; Muggeo M; Adami S
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1250-4. PubMed ID: 10199763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of calcitonin on bone resorption in hyperthyroidism: a placebo-controlled clinical study.
    Akçay MN; Akçay G; BIlen H
    J Bone Miner Metab; 2004; 22(2):90-3. PubMed ID: 14999518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass.
    Jódar E; Begoña López M; García L; Rigopoulou D; Martínez G; Hawkins F
    Osteoporos Int; 1998; 8(4):311-6. PubMed ID: 10024900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: evidence of maximal effect after 8 weeks of continuous treatment.
    Kraenzlin ME; Seibel MJ; Trechsel U; Boerlin V; Azria M; Kraenzlin CA; Haas HG
    Calcif Tissue Int; 1996 Apr; 58(4):216-20. PubMed ID: 8661950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
    Marttunen MB; Hietanen P; Tiitinen A; Ylikorkala O
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes of bone density and bone resorption in hyperthyroid girls during treatment.
    Mora S; Weber G; Marenzi K; Signorini E; Rovelli R; Proverbio MC; Chiumello G
    J Bone Miner Res; 1999 Nov; 14(11):1971-7. PubMed ID: 10571698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
    Downs RW; Bell NH; Ettinger MP; Walsh BW; Favus MJ; Mako B; Wang L; Smith ME; Gormley GJ; Melton ME
    J Clin Endocrinol Metab; 2000 May; 85(5):1783-8. PubMed ID: 10843152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.